-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Cue Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q3 2024.
- Cue Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $155K, a 62.6% decline year-over-year.
- Cue Biopharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.09M, a 15.8% decline year-over-year.
- Cue Biopharma, Inc. annual Nonoperating Income (Expense) for 2023 was $1.42M, a 559% increase from 2022.
- Cue Biopharma, Inc. annual Nonoperating Income (Expense) for 2022 was $215K, a 368% increase from 2021.
- Cue Biopharma, Inc. annual Nonoperating Income (Expense) for 2021 was $45.9K, a 90.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)